Catapult exits FDAS
Catapult Venture Managers has sold Food and Drug Analytical Services (FDAS) to Tentamus UK, the UK subsidiary of German laboratory group Tentamus Group.
Catapult first invested in FDAS in 2004 when the company was established via its East Midlands Regional Venture Capital Fund.
Company
Based in BioCity, Nottingham, FDAS provides pharmaceutical quality control testing services. It offers full-contract testing services, including chemistry, microbiology, stability and development capabilities, to pharmaceutical companies.
The company employs 20 people.
People
Catapult Venture Managers - Jonathan Lowe (head of investor relations).
FDAS - Larissa Taylor (technical director).
Advisers
Vendor - Fraser Brown, Tom Gray, Peter Abel (legal); Smith Hodge & Baxter (financial due diligence).
More on Exits
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Ares Management handed keys to two-thirds of UK sponsor’s portfolio
Lender provided GBP 500m for three of the GP's deals between 2016 and 2019, Debtwire reported
Actera Group explores strategic options for Celebi Ground Handling
Several investors placed bids for the company in 2022 but mismatch in pricing didn't lead to a deal
Main Capital’s Assessio to be sold to Pollen Street
Recruitment software company tripled in revenue under Main Capital’s ownership
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater